Sign in
4

Changes in Ownership

Protagenic Therapeutics, Inc.new Filed Acc 0001437749-16-037066

Director acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Barrage Khalil Director 2016-08-08 Grant or award +150,000 $1.25 $187,500 245,000 D
Loading xslF345X03/rdgdoc.xml…